Leukemia inhibitory factor promotes castration-resistant prostate cancer and neuroendocrine differentiation by activated ZBTB46

PURPOSE: The molecular targets for castration-resistant prostate cancer (CRPC) are unknown because the disease inevitably recurs, and therapeutic approaches for CRPC patients remain less well understood. We sought to investigate regulatory mechanisms that result in increased therapeutic resistance,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Cancer Res
Hauptverfasser: Liu, Yen-Nien, Niu, Shaoxi, Chen, Wei-Yu, Zhang, Qingfu, Tao, Yulei, Chen, Wei-Hao, Jiang, Kuo-Ching, Chen, Xufeng, Shi, Huaiyin, Liu, Aijun, Li, Jinhang, Li, Yanjing, Lee, Yi-Chao, Zhang, Xu, Huang, Jiaoti
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7168873/
https://ncbi.nlm.nih.gov/pubmed/30962287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3239
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge